Keyphrases
Cell-to-cell
20%
Clinical Behavior
20%
Confidence Interval
20%
E-cadherin
100%
Gastric Neuroendocrine Carcinoma
100%
Histological Differentiation
20%
Immunohistochemical Analysis
20%
Immunohistochemical Study
100%
Ki-67
100%
Ki-67 Index
40%
Large Cell Neuroendocrine Carcinoma (LCNEC)
20%
Lymph Node Metastasis
40%
Median Survival
20%
Neuroendocrine Carcinoma
20%
No Significant Difference
20%
Overall Survival
40%
Pathological Classification
20%
Patient Survival
20%
Poor Differentiation
40%
Poorly Differentiated Neuroendocrine Carcinoma
20%
Prognostic Marker
100%
Prognostic Role
20%
Small Cell
20%
Stomach
20%
Therapeutic Guidelines
20%
Tumor
60%
Tumor Pathology
20%
Tumor Recurrence
20%
Well-differentiated
20%
Well-differentiated Neuroendocrine Carcinoma
20%
WHO Classification
20%
Medicine and Dentistry
Large Cell Neuroendocrine Carcinoma
16%
Lymph Node Metastasis
33%
Malignant Neoplasm
16%
Neoplasm
50%
Neuroendocrine Carcinoma
100%
Overall Survival
33%
Tumor Pathology
16%
Tumor Recurrence
16%
Uvomorulin
100%
Pharmacology, Toxicology and Pharmaceutical Science
Large Cell Neuroendocrine Carcinoma
16%
Lymph Node Metastasis
33%
Malignant Neoplasm
16%
Neoplasm
66%
Neuroendocrine Carcinoma
100%
Overall Survival
33%
Tumor Recurrence
16%
Uvomorulin
100%